Related Experiment Video
Updated: Aug 8, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma
Carolyn Mold1, Terry W Du Clos
1Veterans Affairs Medical Center, Albuquerque, NM 87108, USA. cmold@salud.umm.edu
Abstract:
Streptococcus pneumoniae is the most common organism responsible for community acquired pneumonia and meningitis. In pneumococcal pneumonia, a strong local inflammatory cytokine response reduces the frequency of bacteremia and increases survival. The initiation of this cytokine response by innate recognition of bacterial cell wall components through TLR has been described, but the role of soluble innate mediators has received limited attention. C-reactive protein (CRP) is an acute phase protein that binds phosphocholine residues on S. pneumoniae cell walls. CRP interacts with phagocytic cells through FcgammaRI and FcgammaRII and activates the classical complement pathway. CRP is protective in mouse pneumococcal bacteremia by increasing complement-dependent clearance and killing of bacteria. We studied the cytokine response of PBMC stimulated with CRP-opsonized S. pneumoniae to determine the effect of CRP interaction with FcgammaR. CRP dramatically increased the production of TNF-alpha and IL-1beta in response to S. pneumoniae. These increases were blocked by phosphocholine, which inhibits CRP binding to S. pneumoniae, by inhibitors of FcgammaR signaling, and by mAb to FcgammaRI and FcgammaRII. A mutated rCRP with decreased FcgammaR binding had a decreased ability to stimulate TNF-alpha release, compared with wild-type CRP. Individuals who were homozygous for the R-131 allele of FcgammaRIIA, which has a higher affinity for CRP, showed higher responses to CRP-opsonized bacteria than did individuals homozygous for the H-131 allele, further implicating this receptor. The results indicate that CRP recognition of S. pneumoniae and binding to FcgammaR may enhance the early protective cytokine response to infection.
Insights
C-reactive protein (CRP) enhances the immune response to Streptococcus pneumoniae by binding to bacterial cell walls and activating Fc gamma receptors (FcγR). This interaction boosts protective cytokine production, crucial for fighting pneumonia and meningitis.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Streptococcus pneumoniae causes pneumonia and meningitis.
- Cytokine response is key in pneumococcal infections.
- Role of soluble innate mediators like C-reactive protein (CRP) is understudied.
Purpose of the Study:
- Investigate the role of CRP in the cytokine response to S. pneumoniae.
- Determine the effect of CRP-Fc gamma receptor (FcγR) interaction on cytokine production.
Main Methods:
- Stimulated peripheral blood mononuclear cells (PBMCs) with CRP-opsonized S. pneumoniae.
- Blocked CRP-S. pneumoniae binding with phosphocholine.
- Used FcγR signaling inhibitors and monoclonal antibodies (mAbs).
- Compared cytokine release with wild-type and mutated CRP.
Main Results:
- CRP significantly increased TNF-alpha and IL-1beta production.
- Inhibiting CRP binding or FcγR signaling blocked these increases.
- Mutant CRP with reduced FcγR binding showed lower cytokine stimulation.
- Individuals with high-affinity FcγRIIA R-131 allele had stronger responses.
Conclusions:
- CRP binding to S. pneumoniae and FcγR enhances early protective cytokine responses.
- FcγR interaction is critical for CRP-mediated cytokine stimulation.
- CRP-FcγR pathway is important in host defense against pneumococcal infections.
More Related Videos
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
The JAK-STAT Signaling Pathway
Cross-reactivity
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response I: Vascular and Cellular
Allergic Drug Reactions

